IL received advisory/consulting fees and/or other support from: Novo Nordisk, Eli Lilly, Sanofi, Astra Zeneca, Boehringer-Ingelheim, Cytoki Pharma, Johnson and Johnson, Intercept, TARGETPharma, Merck, Pfizer, Valeritas, Zealand Pharma, Shionogi, Carmot Therapeutics, Structure Therapeutics, Bayer, Translational Medical Academy, Mediflix, Biomea, Metsera, Regeneron, The Comm Group, and WebMD
Semaglutide temperature monitoring Semaglutide, a revolutionary drug in the management of chronic conditions like Type 2 diabetes and obesity, has transformed the pharmaceutical landscape with its efficacy and growing accessibility
Within cellular biology research, FOXO proteins are known to participate in signalling networks that regulate gene expression related to cellular stress responses, metabolic activity and programmed cellular processes
More fiber isnt always more balance is everything
New studies continue to explore cardiovascular benefits, effects on fatty liver disease, and potential applications beyond weight loss
A letter of medical necessity is available on request to support FSA or HSA reimbursement submissions